Modern research shows that the clinical manifestations of pathological characters for prostatic hyperplasia emerges complicated symptoms, treatment is often more antibiotics, However, there exist the prostate - lipid envelope blood barrier, which is composed of the lipid membrane.Aperture of the envelope°÷5¶Őm, prevents the most drugs and water-soluble antibiotics getting through, greatly lower the treatment effect. In addition, some of the bacteria secrete glycoprotein matrix, which also hinders the drug composition close to the bacteria.And, when there is the presence of prostate stones, stones can become a refuge for bacteria. These factors constitute the difficulties in the treatment of prostatitis.

The emergence of the medicinal plant preparation of the polymerization HMPc of the prostate health, brings the change to the treatment of the prostate disease .This is a substance that has the strongest effect on the permeability of the blood barrier. Such substances can penetrate the lipid envelope, permeability of more than 98%, drug components play a role in prostate gonad, since the appearance of the mobile site to the site of action, have obvious physiological effects in the extremely low concentrations ,Induced and inhibited proliferation.

1A evidence-based medicine in the treatment of prostatitis, support daily taking HMPc medicinal plants have good efficacy and safety. At present, more and more attention is focused on the development and research of HMPc in the treatment of prostate disease.

The HMP category is the classification of the plant preparations by the European Union Drug Administration


Legal & Privacy Policy   |  Copyright   |  Contact Us   |  Medicine Feedbask  |   Order Online

This site is intended for use by United States residents aged 18 or older only.This website is funded and developed by Seans Drug Institute.
You are encouraged to report negative side effects of prescription drugs to the FDA.Visit, or call 1-800-FDA-1088.
2009-2012 Seans Drug Institute Corporation.All Rights Reserved. Seans Drug Institute.